OTC:EMED | Cash Flow Statement | Electromedical Technologies, Inc

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2024-09-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2024-09-30-$724,643.00$0.00
2024-06-30$231,236.00$0.00
2024-03-31-$836,274.00$0.00-$158,361.00$149,500.00
2023-12-31-$348,657.00$0.00-$50,948.00$0.00$0.00$175.00
2023-09-30-$376,720.00$0.00
2023-06-30-$1.46M$0.00
2023-03-31-$456,063.00$4,557.00-$452,736.00$1.89M-$575,250.00
2022-12-31-$830,087.00$5,469.00-$33,099.00-$57,391.00
2022-09-30-$957,946.00$5,469.00
2022-06-30-$535,931.00$5,469.00
2022-03-31-$1.14M$5,469.00-$317,845.00$104,723.00
2021-12-31-$1.85M$5,469.00-$287,615.00$505,975.00
2021-09-30-$3.3M$5,469.00
2021-06-30-$774,532.00$10,938.00
2021-03-31-$2.56M$5,469.00-$327,237.00$643,098.00
2020-12-31-$410,245.00$5,469.00-$541,016.00$720,452.00
2020-09-30-$2.17M$5,468.00
2020-06-30-$840,255.00$5,469.00
2020-03-31-$451,241.00$5,469.00$699.00$38,182.00
2019-12-31-$513,322.00$5,469.00-$468,319.00$93,225.00
2019-09-30-$190,630.00$5,468.00
2019-06-30-$221,418.00
2019-03-31-$818,969.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2023-12-31-$2.64M$4,557.00-$1.42M$149,705.00$1.74M-$608,211.00
2022-12-31-$3.47M$21,875.00-$773,337.00$758,592.00
2021-12-31-$8.48M$21,875.00-$1.19M$1.31M
2020-12-31-$3.87M$21,875.00-$1.34M$1.6M
2019-12-31-$1.74M$24,457.00-$280,772.00$280,772.00